These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2818908
21. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174 [Abstract] [Full Text] [Related]
22. [A case of anaphylactic shock following the administration of Gd-DTPA]. Nomura M, Takeshita G, Katada K, Nakamura M, Kizukuri T, Ogura Y, Anno H, Koga S. Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Dec 25; 53(12):1387-91. PubMed ID: 8108244 [Abstract] [Full Text] [Related]
23. Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin. Guy J, McGorray S, Fitzsimmons J, Beck B, Rao NA. Invest Ophthalmol Vis Sci; 1994 Mar 25; 35(3):1114-23. PubMed ID: 8125722 [Abstract] [Full Text] [Related]
24. MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA. Runge VM, Jacobson S, Wood ML, Kaufman D, Adelman LS. Radiology; 1988 Mar 25; 166(3):835-8. PubMed ID: 3401296 [Abstract] [Full Text] [Related]
25. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Wang SC, Wikström MG, White DL, Klaveness J, Holtz E, Rongved P, Moseley ME, Brasch RC. Radiology; 1990 May 25; 175(2):483-8. PubMed ID: 1691513 [Abstract] [Full Text] [Related]
26. Magnetic resonance imaging increases the blood-brain barrier permeability to 153-gadolinium diethylenetriaminepentaacetic acid in rats. Prato FS, Frappier JR, Shivers RR, Kavaliers M, Zabel P, Drost D, Lee TY. Brain Res; 1990 Jul 23; 523(2):301-4. PubMed ID: 2400915 [Abstract] [Full Text] [Related]
27. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. J Neurol Neurosurg Psychiatry; 2003 Jan 23; 74(1):70-6. PubMed ID: 12486269 [Abstract] [Full Text] [Related]
28. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings. Roman-Goldstein SM, Barnett PA, McCormick CI, Szumowski J, Shannon EM, Ramsey FL, Mass M, Neuwelt EA. J Comput Assist Tomogr; 1994 Jan 23; 18(5):731-6. PubMed ID: 8089321 [Abstract] [Full Text] [Related]
29. Dyke Award Paper. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR. Schmiedl UP, Kenney J, Maravilla KR. AJNR Am J Neuroradiol; 1992 Jan 23; 13(1):5-14. PubMed ID: 1595491 [Abstract] [Full Text] [Related]
30. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent. Niemi P, Koskinen S, Reisto T. Invest Radiol; 1991 Jul 23; 26(7):674-80. PubMed ID: 1885276 [Abstract] [Full Text] [Related]
31. Quantitative and noninvasive assessment of prenatal X-ray-induced CNS abnormalities using magnetic resonance imaging. Saito S, Aoki I, Sawada K, Sun XZ, Chuang KH, Kershaw J, Kanno I, Suhara T. Radiat Res; 2011 Jan 23; 175(1):1-9. PubMed ID: 21175341 [Abstract] [Full Text] [Related]
32. Spin-lattice relaxation and magnetization transfer in intracranial tumors in vivo: effects of Gd-DTPA on relaxation parameters. Kurki T, Komu M. Magn Reson Imaging; 1995 Jan 23; 13(3):379-85. PubMed ID: 7791547 [Abstract] [Full Text] [Related]
33. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water. Montgomery AB, Paajanen H, Brasch RC, Murray JF. Invest Radiol; 1987 May 23; 22(5):377-81. PubMed ID: 3597005 [Abstract] [Full Text] [Related]
34. Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging. Tabanor K, Lee P, Kiptoo P, Choi IY, Sherry EB, Eagle CS, Williams TD, Siahaan TJ. Mol Pharm; 2016 Feb 01; 13(2):379-90. PubMed ID: 26705088 [Abstract] [Full Text] [Related]
36. Magnetic resonance imaging of experimental rat brain tumors: histopathological evaluation. Baba T, Moriguchi M, Natori Y, Katsuki C, Inoue T, Fukui M. Surg Neurol; 1990 Dec 01; 34(6):378-82. PubMed ID: 2244301 [Abstract] [Full Text] [Related]
37. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Kenney J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A, Nelson J. Magn Reson Med; 1992 Sep 01; 27(1):68-75. PubMed ID: 1435211 [Abstract] [Full Text] [Related]
38. Magnetic resonance imaging of gadolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain. Kornguth SE, Turski PA, Perman WH, Schultz R, Kalinke T, Reale R, Raybaud F. J Neurosurg; 1987 Jun 01; 66(6):898-906. PubMed ID: 3494823 [Abstract] [Full Text] [Related]
39. Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature. Norman AB, Bertram KJ, Thomas SR, Pratt RG, Samaratunga RC, Sanberg PR. Brain Res Bull; 1991 Apr 01; 26(4):593-7. PubMed ID: 1907878 [Abstract] [Full Text] [Related]
40. Disruption of the blood-cerebrospinal fluid barrier by transient cerebral ischemia. Nagahiro S, Goto S, Korematsu K, Sumi M, Takahashi M, Ushio Y. Brain Res; 1994 Jan 07; 633(1-2):305-11. PubMed ID: 8137165 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]